Pfizer posts Q3 loss as Covid-19 revenues shrink
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Additional premium services in RegXcellence will include access to BASF’s Product Carbon Footprint data and direct downloads of audit reports
GenWorks Health Introduces Braster Pro for breast screening & EVA for cervical screening in rural areas & communities
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer
Increased capability to produce medicines for challenging diseases including cancer
Subscribe To Our Newsletter & Stay Updated